IL-27 belongs to the
IL-12 family of
cytokines and has been described not only to support T-cell polarization along the Th1 lineage, but also to induce important anti-inflammatory responses in later phases of
inflammation. We and others have previously shown that the
cytokine IL-27 has an important impact on the chronic manifestation of inflammatory
skin diseases. Thus, the aim of this study was to specify the effects of
IL-27 on the human antigen-presenting cell (APC) subtype inflammatory dendritic epidermal cells (IDEC), which are known to play an important role in
eczema. IDEC and blood-derived human macrophages were generated from human peripheral blood and stimulated with
IL-27. Functional responses of the cells were analysed by intracellular
cytokine staining, ELISA and FlowCytomix.
IL-27 was found to be the only
IL-12 family member that acts on human APC as a priming signal for
IL-23 but not
IL-12 production. We confirmed for macrophages that
IL-27 limits
lipopolysaccharide-induced
IL-10 production and detected the same tendency for IDEC. Furthermore, we showed that this also applies to CD40L-induced
IL-10 expression in both investigated human APC subsets. We demonstrate that
IL-27 exerts pro-inflammatory effects on human APC in particular in the context of a range of bacterial-derived TLR
ligands. Hence, our study builds upon the idea that
IL-27 exerts a pro-inflammatory effect on innate immune and tissue-resident cells and may drive eczematous reaction - in particular in the context of bacterial
superinfection - towards a chronic phase.